Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Investig Med. 2018 Jul 2;66(7):1055–1063. doi: 10.1136/jim-2018-000717

Figure 3.

Figure 3

ROC analysis of BC200 RNA expression in peripheral blood of patients with invasive breast cancer To ascertain the discriminative diagnostic power of the BC200 RNA blood test, receiver operating characteristic (ROC) analysis was performedby plotting sensitivity against (1−specificity), comparing BC200 RNA levels in blood from healthy subjects with BC200 RNA levels in presurgery patients with invasive breast cancer (group Primary Disease I) The obtained ROC curve shows an area under the curve of 089 (95% CI of 077 to 10), indicating a high discriminative efficacy of the BC200 RNA test.